Genedata Advances R&D Efficiency with New Unified Sample Management Solution
Fully integrated biological sample management enables precise and efficient tracking of physical samples, their storage locations, and their histories across the full sample life cycle, including production, aliquoting, barcoding, distribution, and final disposal
Biotherapeutics R&D involves managing a high volume of samples such as plasmids, cell banks, and purified proteins produced by different groups and stored in freezers or cryobanks at different sites. Sample tracking, often relying on local, decentralized, or home-grown inventory software, is time-consuming, costly, and prone to errors.
Genedata's new Sample Management solution addresses this challenge by offering a dedicated new module for managing the precise physical location of each sample across different groups and sites, down to the building, shelf, and container. This ensures accurate tracking of each sample, enabling compliant and efficient inventory control, sample storage, location, requesting, and distribution. By being directly integrated with the Genedata bioregistration engine, the content and history of all samples are accessible at any time, whether it is a protein, plasmid, cell line, or complex mixture.
What makes this solution unique is its seamless integration within the Genedata Biopharma Platform, including Genedata Biologics® and Genedata Bioprocess®. This allows sample location data to be automatically linked with all relevant contextual information and metadata such as batch records, molecule properties, genealogy, and assay or QC results. No other software on the market offers this level of connectivity and information traceability within a single, fully integrated platform. By eliminating the need for external inventory systems, system integration, or data synchronization, it provides a unified, reliable source of truth for all biological samples.
Developed in close collaboration with leading biopharma partners, the new module combines robustness with ease of use. It supports configurable inventory hierarchies tailored to diverse laboratory environments, downloadable storage views for collaboration, and container dashboards for placing and retrieving aliquots. Importantly, all sample inventory and ordering processes can be fully automated. With sample quantity tracking capabilities, it adds spatial awareness and operational control to further improve efficiency and reduce risk.
"Recognizing the limitations of existing inventory and sample management solutions, we set out to build a fully integrated module designed to transform laboratory logistics," said
About Genedata
Genedata, a Danaher company, transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in
www.genedata.com
LinkedIn | YouTube
About Danaher
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology – and proven ability to innovate – help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
View original content to download multimedia:https://www.prnewswire.com/news-releases/genedata-advances-rd-efficiency-with-new-unified-sample-management-solution-302539968.html
SOURCE Genedata
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baloo Living and Inhabit Hotels Partner to Bring Restorative Sleep Experience to Guests with Weighted Blankets
- Binance Blockchain Week 2026 Returns to Asia: Spotlights the Evolution of Finance in Bangkok
- Basware Turns $10 Trillion in Transaction Data Into New Intelligence for Finance Performance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share